Global and Region Artificial Hearts and Circulatory Assist Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Artificial Hearts and Circulatory Assist market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Artificial Hearts and Circulatory Assistmarket, defines the market attractiveness level of Artificial Hearts and Circulatory Assist market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Artificial Hearts and Circulatory Assist industry, describes the types of Artificial Hearts and Circulatory Assist market, the applications of major players and the market size, and deeply analyzes the current situation of the global Artificial Hearts and Circulatory Assist market and the development prospects and opportunities of Artificial Hearts and Circulatory Assist industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Artificial Hearts and Circulatory Assist market in Chapter 13.

    By Player:

    • ABIOMED

    • SynCardia Systems

    • BiVACOR

    • LivaNova PLC

    • CARMAT

    • Jarvik Heart Inc

    • Berlin Heart

    • Abbott Laboratories

    • Medtronic PLC

    • Yongrenxin Medical

    By Type:

    • Ventricular Assist Devices

    • Artificial Heart

    By End-User:

    • Coronary Heart Disease

    • Cerebrovascular Disease

    • Peripheral Arterial Disease

    • Rheumatic Heart Disease

    • Congenital Heart Disease

    • Deep Vein Thrombosis

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Artificial Hearts and Circulatory Assist Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Artificial Hearts and Circulatory Assist Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Artificial Hearts and Circulatory Assist Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Artificial Hearts and Circulatory Assist Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Artificial Hearts and Circulatory Assist Market Analysis and Outlook to 2022

    • 7.1 Global Artificial Hearts and Circulatory Assist Consumption (2017-2022)

    • 7.2 United States Artificial Hearts and Circulatory Assist Consumption (2017-2022)

    • 7.3 Europe Artificial Hearts and Circulatory Assist Consumption (2017-2022)

    • 7.4 China Artificial Hearts and Circulatory Assist Consumption (2017-2022)

    • 7.5 Japan Artificial Hearts and Circulatory Assist Consumption (2017-2022)

    • 7.6 India Artificial Hearts and Circulatory Assist Consumption (2017-2022)

    • 7.7 South Korea Artificial Hearts and Circulatory Assist Consumption (2017-2022)

    8 Region and Country-wise Artificial Hearts and Circulatory Assist Market Analysis and Outlook to 2028

    • 8.1 Global Artificial Hearts and Circulatory Assist Consumption Forecast (2022-2028)

    • 8.2 United States Artificial Hearts and Circulatory Assist Consumption Forecast (2022-2028)

    • 8.3 Europe Artificial Hearts and Circulatory Assist Consumption Forecast (2022-2028)

    • 8.4 China Artificial Hearts and Circulatory Assist Consumption Forecast (2022-2028)

    • 8.5 Japan Artificial Hearts and Circulatory Assist Consumption Forecast (2022-2028)

    • 8.6 India Artificial Hearts and Circulatory Assist Consumption Forecast (2022-2028)

    • 8.7 South Korea Artificial Hearts and Circulatory Assist Consumption Forecast (2022-2028)

    9 Global Artificial Hearts and Circulatory Assist Market Outlook by Types and Applications to 2022

    • 9.1 Global Artificial Hearts and Circulatory Assist Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Ventricular Assist Devices Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Artificial Heart Consumption and Growth Rate (2017-2022)

    • 9.2 Global Artificial Hearts and Circulatory Assist Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Coronary Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cerebrovascular Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Peripheral Arterial Disease Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Rheumatic Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Congenital Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Deep Vein Thrombosis Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Artificial Hearts and Circulatory Assist Market Outlook by Types and Applications to 2028

    • 10.1 Global Artificial Hearts and Circulatory Assist Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Ventricular Assist Devices Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Artificial Heart Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Artificial Hearts and Circulatory Assist Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Coronary Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cerebrovascular Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Peripheral Arterial Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Rheumatic Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Congenital Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Deep Vein Thrombosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Artificial Hearts and Circulatory Assist Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Artificial Hearts and Circulatory Assist Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Artificial Hearts and Circulatory Assist Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Artificial Hearts and Circulatory Assist Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Artificial Hearts and Circulatory Assist Market Competitive Analysis

    • 14.1 ABIOMED

      • 14.1.1 ABIOMED Company Details

      • 14.1.2 ABIOMED Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 ABIOMED Artificial Hearts and Circulatory Assist Product and Service

    • 14.2 SynCardia Systems

      • 14.2.1 SynCardia Systems Company Details

      • 14.2.2 SynCardia Systems Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 SynCardia Systems Artificial Hearts and Circulatory Assist Product and Service

    • 14.3 BiVACOR

      • 14.3.1 BiVACOR Company Details

      • 14.3.2 BiVACOR Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 BiVACOR Artificial Hearts and Circulatory Assist Product and Service

    • 14.4 LivaNova PLC

      • 14.4.1 LivaNova PLC Company Details

      • 14.4.2 LivaNova PLC Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 LivaNova PLC Artificial Hearts and Circulatory Assist Product and Service

    • 14.5 CARMAT

      • 14.5.1 CARMAT Company Details

      • 14.5.2 CARMAT Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 CARMAT Artificial Hearts and Circulatory Assist Product and Service

    • 14.6 Jarvik Heart Inc

      • 14.6.1 Jarvik Heart Inc Company Details

      • 14.6.2 Jarvik Heart Inc Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Jarvik Heart Inc Artificial Hearts and Circulatory Assist Product and Service

    • 14.7 Berlin Heart

      • 14.7.1 Berlin Heart Company Details

      • 14.7.2 Berlin Heart Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Berlin Heart Artificial Hearts and Circulatory Assist Product and Service

    • 14.8 Abbott Laboratories

      • 14.8.1 Abbott Laboratories Company Details

      • 14.8.2 Abbott Laboratories Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Abbott Laboratories Artificial Hearts and Circulatory Assist Product and Service

    • 14.9 Medtronic PLC

      • 14.9.1 Medtronic PLC Company Details

      • 14.9.2 Medtronic PLC Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Medtronic PLC Artificial Hearts and Circulatory Assist Product and Service

    • 14.10 Yongrenxin Medical

      • 14.10.1 Yongrenxin Medical Company Details

      • 14.10.2 Yongrenxin Medical Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Yongrenxin Medical Artificial Hearts and Circulatory Assist Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Artificial Hearts and Circulatory Assist

    • Figure Artificial Hearts and Circulatory Assist Picture

    • Table Global Artificial Hearts and Circulatory Assist Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Artificial Hearts and Circulatory Assist Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Artificial Hearts and Circulatory Assist Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Artificial Hearts and Circulatory Assist Consumption by Country (2017-2022)

    • Figure United States Artificial Hearts and Circulatory Assist Consumption and Growth Rate (2017-2022)

    • Table Europe Artificial Hearts and Circulatory Assist Consumption and Growth Rate (2017-2022)

    • Figure China Artificial Hearts and Circulatory Assist Consumption and Growth Rate (2017-2022)

    • Figure Japan Artificial Hearts and Circulatory Assist Consumption and Growth Rate (2017-2022)

    • Figure India Artificial Hearts and Circulatory Assist Consumption and Growth Rate (2017-2022)

    • Figure South Korea Artificial Hearts and Circulatory Assist Consumption and Growth Rate (2017-2022)

    • Figure Global Artificial Hearts and Circulatory Assist Consumption Forecast by Country (2022-2028)

    • Figure United States Artificial Hearts and Circulatory Assist Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Artificial Hearts and Circulatory Assist Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Artificial Hearts and Circulatory Assist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Artificial Hearts and Circulatory Assist Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Artificial Hearts and Circulatory Assist Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Artificial Hearts and Circulatory Assist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ventricular Assist Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Artificial Heart Consumption and Growth Rate (2017-2022)

    • Figure Global Coronary Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cerebrovascular Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Peripheral Arterial Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Rheumatic Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Congenital Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Deep Vein Thrombosis Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Ventricular Assist Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Artificial Heart Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coronary Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cerebrovascular Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Peripheral Arterial Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rheumatic Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Congenital Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Deep Vein Thrombosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Artificial Hearts and Circulatory Assist Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Artificial Hearts and Circulatory Assist Export by Region (Top 5 Countries) (2017-2028)

    • Table ABIOMED (Foundation Year, Company Profile and etc.)

    • Table ABIOMED Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table ABIOMED Artificial Hearts and Circulatory Assist Product and Service

    • Table SynCardia Systems (Foundation Year, Company Profile and etc.)

    • Table SynCardia Systems Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table SynCardia Systems Artificial Hearts and Circulatory Assist Product and Service

    • Table BiVACOR (Foundation Year, Company Profile and etc.)

    • Table BiVACOR Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table BiVACOR Artificial Hearts and Circulatory Assist Product and Service

    • Table LivaNova PLC (Foundation Year, Company Profile and etc.)

    • Table LivaNova PLC Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table LivaNova PLC Artificial Hearts and Circulatory Assist Product and Service

    • Table CARMAT (Foundation Year, Company Profile and etc.)

    • Table CARMAT Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table CARMAT Artificial Hearts and Circulatory Assist Product and Service

    • Table Jarvik Heart Inc (Foundation Year, Company Profile and etc.)

    • Table Jarvik Heart Inc Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jarvik Heart Inc Artificial Hearts and Circulatory Assist Product and Service

    • Table Berlin Heart (Foundation Year, Company Profile and etc.)

    • Table Berlin Heart Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table Berlin Heart Artificial Hearts and Circulatory Assist Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Artificial Hearts and Circulatory Assist Product and Service

    • Table Medtronic PLC (Foundation Year, Company Profile and etc.)

    • Table Medtronic PLC Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic PLC Artificial Hearts and Circulatory Assist Product and Service

    • Table Yongrenxin Medical (Foundation Year, Company Profile and etc.)

    • Table Yongrenxin Medical Artificial Hearts and Circulatory Assist Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yongrenxin Medical Artificial Hearts and Circulatory Assist Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.